Home
/
Treatment
/
(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl]...

(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019

	(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019
Trade Name
Orphan Indication	Glioma
USA Market Approval	USA
USA Designation Date	2011-03-18 00:00:00
Sponsor	NATCO Pharma Limited;Natco House;Hyderbad 500033

Related Access Program

Center Trials & Treatment – Glioma of Brain Oncoceutics, Inc. – Glioma